OrbiMed Genesis GP LLC
Director, 10% owner, Prelude Therapeutics Inc
Bought, 12 months
$12.5M
Sold, 12 months
$0.0M
Companies
1
Latest trade
Apr 21, 2026
Companies
Prelude Therapeutics IncDirector, 10% owner +$12.5M
Trades
Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.